^
    Back
    Association details:
    Biomarker:ITGA4 negative
    Cancer:Chronic Lymphocytic Leukemia
    Drug:lenalidomide (TNFα inhibitor, IL-6 inhibitor, IL-12 inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: D – Preclinical
    Source:
    Hematol Oncol
    Title:

    Lenalidomide abrogates the survival effect of bone marrow stromal cells in chronic lymphocytic leukemia

    Published date:
    05/20/2021
    Excerpt:
    CD49d-negative CLL cases were more sensitive to lenalidomide treatment.
    DOI:
    10.1002/hon.2888